Neutrophil granulocytes - Trojan horses for Leishmania major and other intracellular microbes?

Trends in Microbiology

Volumn 11, Issue 5, 2003, Pages 210-214

  Laskay, Tamás ^a   Van Zandbergen, Ger ^a   Solbach, Werner ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOTACTIC FACTOR; CHEMOTACTIC PEPTIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN; INTERLEUKIN 8; MANNAN BINDING LECTIN; OPSONIN;

APOPTOSIS; BONE MARROW; BONE MARROW CELL; BORDETELLA PERTUSSIS; BRUCELLA ABORTUS; BURKHOLDERIA PSEUDOMALLEI; CELL CYCLE; CELL FUNCTION; CELL MANIPULATION; CELL MIGRATION; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; EFFECTOR CELL; EHRLICHIOSIS; ESCHERICHIA; FRANCISELLA TULARENSIS; HELPER CELL; HISTOPHILUS SOMNI; HISTOPLASMA CAPSULATUM; HORSE; HOST CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INGESTION; INTRACELLULAR KILLING; INTRACELLULAR SPACE; LEGIONELLA PNEUMOPHILA; LEISHMANIA MAJOR; LEUKOCYTE; MACROPHAGE; MICROBIAL KINETICS; MICROORGANISM; MONOCYTE; MYCOBACTERIUM LEPRAE; NATURAL KILLER CELL; NEISSERIA GONORRHOEAE; NEUTROPHIL; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PARASITOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TOXOPLASMA GONDII; YERSINIA ENTEROCOLITICA;

AJELLOMYCES; AJELLOMYCES CAPSULATUS; BORDETELLA; BORDETELLA PERTUSSIS; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; EQUIDAE; EQUUS CABALLUS; ESCHERICHIA; FRANCISELLA TULARENSIS; HAEMOPHILUS; HISTOPHILUS SOMNI; LEGIONELLA; LEGIONELLA PNEUMOPHILA; LEISHMANIA MAJOR; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; NEISSERIA; NEISSERIA GONORRHOEAE; PROTOZOA; SALMONELLA TYPHI; SALMONELLA TYPHIMURIUM; TOXOPLASMA GONDII; YERSINIA; YERSINIA ENTEROCOLITICA;

EID: 0037674823     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(03)00075-1     Document Type: Review

References (50)

1. Witko-Sarsat V., et al. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 80:2000;617-653.
2. Gainet J., et al. Interleukin-8 production by polymorphonuclear neutrophils in patients with rapidly progressive periodontitis: an amplifying loop of polymorphonuclear neutrophil activation. Lab. Invest. 78:1998;755-762.
3. Sunderkotter C., et al. Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo. J. Immunol. 151:1993;4891-4901.
4. Muller K., et al. Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med. Microbiol. Immunol. (Berl.). 190:2001;73-76.
5. Laufs H., et al. Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infect. Immun. 70:2002;826-835.
6. Scapini P., et al. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177:2000;195-203.
7. Molestina R.E., et al. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect. Immun. 67:1999;1323-1330.
8. Chensue S.W. Molecular machinations: chemokine signals in host-pathogen interactions. Clin. Microbiol. Rev. 14:2001;821-835.
9. + Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165:2000;2628-2636.
10. van Zandbergen G., et al. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infect. Immun. 70:2002;4177-4184.
11. Cassatella M.A., et al. Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur. J. Immunol. 27:1997;111-115.
12. Mozaffarian N., et al. Inhibition of human endothelial cell chemokine production by the opportunistic fungal pathogen Cryptococcus neoformans. J. Immunol. 165:2000;1541-1547.
13. Ofek I., et al. Nonopsonic phagocytosis of microorganisms. Annu. Rev. Microbiol. 49:1995;239-276.
14. Uthaisangsook S., et al. Innate immunity and its role against infections. Ann. Allergy Asthma Immunol. 88:2002;253-264.
15. Gokce H.I., et al. Inhibition of phagosome-lysosome fusion in ovine polymorphonuclear leucocytes by Ehrlichia (Cytoecetes) phagocytophila. J. Comp. Pathol. 120:1999;369-381.
16. Mott J., Rikihisa Y. Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. Infect. Immun. 68:2000;6697-6703.
17. Kossack R.E., et al. Diminished neutrophil oxidative metabolism after phagocytosis of virulent Salmonella typhi. Infect. Immun. 31:1981;674-678.
18. Kreutzer D.L., et al. Interaction of polymorphonuclear leukocytes with smooth and rough strains of Brucella abortus. Infect. Immun. 23:1979;737-742.
19. Holzer T.J., et al. Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation. Infect. Immun. 51:1986;514-520.
20. Sandstrom G., et al. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56:1988;1194-1202.
21. Ruckdeschel K., et al. Differential contribution of Yersinia enterocolitica virulence factors to evasion of microbicidal action of neutrophils. Infect. Immun. 64:1996;724-733.
22. Czuprynski C.J., Hamilton H.L. Bovine neutrophils ingest but do not kill Haemophilus somnus in vitro. Infect. Immun. 50:1985;431-436.
23. Steed L.L., et al. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J. Leukoc. Biol. 50:1991;321-330.
24. Witt K., et al. Resistance of Neisseria gonorrhoeae grown in vivo to ingestion and digestion by phagocytes of human blood. J. Gen. Microbiol. 96:1976;341-350.
25. Chiu C.H., Ou J.T. Intracellular Salmonella typhimurium induce lysis of human polymorphonuclear leukocytes which is not associated with the Salmonella virulence plasmid. Microbiol. Immunol. 43:1999;9-14.
26. Dunlap N.E., et al. A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells. Microb. Pathog. 13:1992;181-190.
27. Miyamoto H., et al. Temperature effects on Legionella pneumophila killing by and multiplication in phagocytes of guinea pigs. Microbiol. Immunol. 39:1995;647-654.
28. Medeiros A.I., et al. Histoplasma capsulatum inhibits apoptosis and Mac-1 expression in leucocytes. Scand. J. Immunol. 56:2002;392-398.
29. Egan A.M., Gordon D.L. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infect. Immun. 64:1996;4952-4959.
30. Register K.B., et al. Interaction between Chlamydia spp. and human polymorphonuclear leukocytes in vitro. Infect. Immun. 52:1986;664-670.
31. Mirkovich A.M., et al. Increased myelopoiesis during Leishmania major infection in mice: generation of 'safe targets', a possible way to evade the effector immune mechanism. Clin. Exp. Immunol. 64:1986;1-7.
32. Squier M.K., et al. Apoptosis in leukocytes. J. Leukoc. Biol. 57:1995;2-10.
33. Colotta F., et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 80:1992;2012-2020.
34. DosReis G.A., Barcinski M.A. Apoptosis and parasitism: from the parasite to the host immune response. Adv. Parasitol. 49:2001;133-161.
35. Monack D., Falkow S. Apoptosis as a common bacterial virulence strategy. Int. J. Med. Microbiol. 290:2000;7-11.
36. Rotstein D., et al. Phagocytosis of Candida albicans induces apoptosis of human neutrophils. Shock. 14:2000;278-283.
37. Watson R.W., et al. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J. Immunol. 156:1996;3986-3992.
38. Heussler V.T., et al. The intracellular parasite Theileria parva protects-infected T cells from apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7312-7317.
39. Nash P.B., et al. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J. Immunol. 160:1998;1824-1830.
40. Yoshiie K., et al. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect. Immun. 68:2000;1125-1133.
41. Aga E., et al. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J. Immunol. 169:2002;898-905.
42. Menten P., et al. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 13:2002;455-481.
43. Solbach W., Laskay T. The host response to Leishmania infection. Adv. Immunol. 74:2000;275-317.
44. Locksley R.M., et al. Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote. Infect. Immun. 56:1988;336-344.
45. Fadok V.A., et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216.
46. Savill J.S., et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83:1989;865-875.
47. Meagher L.C., et al. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J. Leukoc. Biol. 52:1992;269-273.
48. Fadok V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:1998;890-898.
49. Sun E.W., Shi Y.F. Apoptosis: the quiet death silences the immune system. Pharmacol. Ther. 92:2001;135-145.
50. Stuart L.M., et al. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J. Immunol. 168:2002;1627-1635.